The trademark application IMDYLLTRA was filed by Amgen Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 18, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 44 with Providing medical information and patient support services, namely, providing medical information in the fields of pharmaceuticals and the treatment of various illnesses and disorders.